Travere Therapeutics (TVTX) EBIT Margin (2013 - 2026)
Travere Therapeutics (TVTX) posted EBIT Margin of -30.33% for Q3 2026, down 45.45 percentage points from 15.12% a year earlier and down 32.66 percentage points from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) EBIT Margin (2013 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, EBIT Margin at Travere Therapeutics was -20.50%, up 0.40 percentage points year-over-year; for FY2025, it was -12.80%, up 126.08 percentage points from FY2024.
- Annual EBIT Margin has increased for three consecutive years, with a five-year change of +76.03 percentage points (FY2020 to FY2025).
- In prior years, Travere Therapeutics' EBIT Margin was -138.88% in FY2024 (+128.37 pp), -267.24% in FY2023 (+24.93 pp) and -292.17% in FY2022.
- The Q3 2026 figure stands as the lowest quarterly EBIT Margin since Q1 2025.
- On a year-over-year basis, EBIT Margin increased in seven of the last eight quarters, with an average year-over-year change of +84.75 percentage points.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q4 2022, with a gain of 411.57 percentage points; the weakest was Q4 2021, with a drop of 474.55 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was 2.33% (Q2 2026), -29.02% (Q1 2026) and -25.00% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 32.98% |
| 10 | Travere Therapeutics | 4.85 Bn | 4.44 Bn | 221.70 Mn | -30.33% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -30.33% |
| Jun 30, 2026 | 2.33% |
| Mar 31, 2026 | -29.02% |
| Dec 31, 2025 | -25.00% |
| Sep 30, 2025 | 15.12% |
| Jun 30, 2025 | -11.05% |
| Mar 31, 2025 | -52.21% |
| Dec 31, 2024 | -81.21% |
| Sep 30, 2024 | -89.27% |
| Jun 30, 2024 | -125.11% |
| Mar 31, 2024 | -336.53% |
| Dec 31, 2023 | -209.13% |
| Sep 30, 2023 | -249.59% |
| Jun 30, 2023 | -322.87% |
| Mar 31, 2023 | -315.23% |
| Dec 31, 2022 | -295.52% |
| Sep 30, 2022 | -294.23% |
| Jun 30, 2022 | -274.24% |
| Mar 31, 2022 | -307.45% |
| Dec 31, 2021 | -707.08% |
API Access
Travere Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();